Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ornit Chiba-Falek

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Current Opinion in Genetics & Development|March 21, 2017
Structural variants in SNCA gene and the implication to synucleinopathiesOrnit Chiba-Falek
Expert Review of Precision Medicine and Drug Development|September 26, 2017
Towards precision medicine in Alzheimer's disease: deciphering genetic data to establish informative biomarkersOrnit Chiba-Falek, Michael W Lutz
Alzheimer'S & Dementia (New York, N. Y.)|March 1, 2022
Bioinformatics pipeline to guide late-onset Alzheimer's disease (LOAD) post-GWAS studies: Prioritizing transcription regulatory variants within LOAD-associated regionsMichael W Lutz, Ornit Chiba-Falek
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 30, 2023
Bioinformatics pipeline to guide post-GWAS studies in Alzheimer's: A new catalogue of disease candidate short structural variantsMichael W Lutz, Ornit Chiba-Falek
International Journal of Molecular Sciences|January 30, 2021
<i>APOE</i>: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer'sAnna Yang, Boris Kantor, Ornit Chiba-Falek
Molecular Therapy. Nucleic Acids|August 13, 2025
Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative diseaseBoris Kantor, Bernadette O'Donovan, Ornit Chiba-Falek
Molecular Therapy. Nucleic Acids|December 22, 2023
Neuronal-type-specific epigenome editing to decrease <i>SNCA</i> expression: Implications for precision medicine in synucleinopathiesZhiguo Sun, Boris Kantor, Ornit Chiba-Falek
Disease Models & Mechanisms|August 30, 2020
Sex-dependent effect of <i>APOE</i> on Alzheimer's disease and other age-related neurodegenerative disordersJulia Gamache, Young Yun, Ornit Chiba-Falek
Plos One|May 4, 2018
Probing the role of PPARγ in the regulation of late-onset Alzheimer's disease-associated genesJulio Barrera, Shobana Subramanian, Ornit Chiba-Falek
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2019
Bioinformatics strategy to advance the interpretation of Alzheimer's disease GWAS discoveries: The roads from association to causationMichael W Lutz, Daniel Sprague, Ornit Chiba-Falek
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Current Opinion in Genetics & Development|March 21, 2017
Structural variants in SNCA gene and the implication to synucleinopathiesOrnit Chiba-Falek
Expert Review of Precision Medicine and Drug Development|September 26, 2017
Towards precision medicine in Alzheimer's disease: deciphering genetic data to establish informative biomarkersOrnit Chiba-Falek, Michael W Lutz
Alzheimer'S & Dementia (New York, N. Y.)|March 1, 2022
Bioinformatics pipeline to guide late-onset Alzheimer's disease (LOAD) post-GWAS studies: Prioritizing transcription regulatory variants within LOAD-associated regionsMichael W Lutz, Ornit Chiba-Falek
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 30, 2023
Bioinformatics pipeline to guide post-GWAS studies in Alzheimer's: A new catalogue of disease candidate short structural variantsMichael W Lutz, Ornit Chiba-Falek
International Journal of Molecular Sciences|January 30, 2021
<i>APOE</i>: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer'sAnna Yang, Boris Kantor, Ornit Chiba-Falek
Molecular Therapy. Nucleic Acids|August 13, 2025
Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative diseaseBoris Kantor, Bernadette O'Donovan, Ornit Chiba-Falek
Molecular Therapy. Nucleic Acids|December 22, 2023
Neuronal-type-specific epigenome editing to decrease <i>SNCA</i> expression: Implications for precision medicine in synucleinopathiesZhiguo Sun, Boris Kantor, Ornit Chiba-Falek
Disease Models & Mechanisms|August 30, 2020
Sex-dependent effect of <i>APOE</i> on Alzheimer's disease and other age-related neurodegenerative disordersJulia Gamache, Young Yun, Ornit Chiba-Falek
Plos One|May 4, 2018
Probing the role of PPARγ in the regulation of late-onset Alzheimer's disease-associated genesJulio Barrera, Shobana Subramanian, Ornit Chiba-Falek
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2019
Bioinformatics strategy to advance the interpretation of Alzheimer's disease GWAS discoveries: The roads from association to causationMichael W Lutz, Daniel Sprague, Ornit Chiba-Falek
Pageof 8